Related Experiment Video
Updated: Jan 26, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Invasive group A streptococcal disease: Management and chemoprophylaxis
Dorothy L Moore1, Upton D Allen1, Timothy Mailman1
1Canadian Paediatric Society, Infectious Diseases and Immunization Committee, Ottawa, Ontario.
Invasive group A streptococcal disease (IGAS) is rising in Canada. This update focuses on IGAS chemoprophylaxis for contacts and clinical management, reaffirming penicillin
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Invasive group A streptococcal disease (IGAS) reporting has increased in Canada.
- Variable adherence to existing Canadian IGAS guidelines necessitates an update.
- Optimal chemoprophylaxis and management are crucial for IGAS control.
Purpose of the Study:
- To update Canadian guidelines for IGAS chemoprophylaxis and clinical management.
- To provide clear recommendations on treating IGAS cases.
- To summarize preferred agents for IGAS chemoprophylaxis.
Main Methods:
- Review and update of existing Canadian guidelines for IGAS.
- Focus on chemoprophylaxis strategies for close contacts of IGAS patients.
- Discussion of antibiotic choices, including penicillin and clindamycin.
Main Results:
- Penicillin remains the primary treatment for group A streptococcal disease.
- Clindamycin's role in IGAS treatment is clarified.
- Preferred chemoprophylactic agents for IGAS contacts are summarized.
Conclusions:
- Updated guidance is essential due to rising IGAS rates in Canada.
- Clearer protocols for IGAS management and chemoprophylaxis are provided.
- This practice point aims to improve consistent application of guidelines across Canada.
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Rheumatic Heart Disease III: Medical Management
Peripheral Artery Disease V: Postoperative Nursing Management
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment

